Effects of Intermittent Fasting on Obesity and Neurological Health

Abstract

Intermittent fasting (IF) has gained growing attention in recent years as a promising dietary intervention for weight management and improving overall health. This review explores the impact of intermittent fasting on obesity and neurological health by analyzing preclinical and clinical studies. IF has shown significant benefits in reducing body weight, enhancing insulin sensitivity, and modulating metabolic biomarkers. Additionally, IF exhibits neuroprotective properties through the regulation of oxidative stress, inflammation, and neurotrophic factors, suggesting its potential in preventing neurodegenerative diseases such as Alzheimer's and Parkinson's. However, further long-term human studies are needed to establish standardized IF protocols and to fully understand its mechanisms. This review aims to highlight the physiological and neurological benefits of intermittent fasting and guide future research and therapeutic applications.